ION BEAM APPLICATIONS (IBAB.BR) Stock Fundamental Analysis
Europe - Euronext Brussels - EBR:IBAB - BE0003766806 - Common Stock
11.12 EUR
+0.08 (+0.72%)
Taking everything into account, IBAB scores 4 out of 10 in our fundamental rating. IBAB was compared to 65 industry peers in the Health Care Equipment & Supplies industry. While IBAB is still in line with the averages on profitability rating, there are concerns on its financial health. IBAB has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year IBAB was profitable.
IBAB had a positive operating cash flow in the past year.
Of the past 5 years IBAB 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: IBAB reported negative operating cash flow in multiple years.
1.2 Ratios
IBAB has a Return On Assets (2.71%) which is in line with its industry peers.
IBAB has a Return On Equity of 14.29%. This is in the better half of the industry: IBAB outperforms 78.46% of its industry peers.
IBAB's Return On Invested Capital of 15.54% is amongst the best of the industry. IBAB outperforms 93.85% of its industry peers.
IBAB had an Average Return On Invested Capital over the past 3 years of 6.20%. This is below the industry average of 9.72%.
The last Return On Invested Capital (15.54%) for IBAB is above the 3 year average (6.20%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROIC | 15.54% |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
1.3 Margins
IBAB has a worse Profit Margin (2.85%) than 60.00% of its industry peers.
IBAB's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 6.48%, IBAB perfoms like the industry average, outperforming 43.08% of the companies in the same industry.
In the last couple of years the Operating Margin of IBAB has grown nicely.
IBAB has a Gross Margin of 31.21%. This is amonst the worse of the industry: IBAB underperforms 84.62% of its industry peers.
IBAB's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% |
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IBAB is creating value.
The number of shares outstanding for IBAB has been increased compared to 1 year ago.
IBAB has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, IBAB has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.61, we must say that IBAB is in the distress zone and has some risk of bankruptcy.
IBAB's Altman-Z score of 1.61 is on the low side compared to the rest of the industry. IBAB is outperformed by 67.69% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that IBAB is not too dependend on debt financing.
The Debt to Equity ratio of IBAB (0.23) is better than 69.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.61 |
ROIC/WACC2.17
WACC7.17%
2.3 Liquidity
A Current Ratio of 0.94 indicates that IBAB may have some problems paying its short term obligations.
IBAB has a worse Current ratio (0.94) than 86.15% of its industry peers.
IBAB has a Quick Ratio of 0.94. This is a bad value and indicates that IBAB is not financially healthy enough and could expect problems in meeting its short term obligations.
IBAB has a Quick ratio of 0.62. This is amonst the worse of the industry: IBAB underperforms 86.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
IBAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 112.86%, which is quite impressive.
IBAB shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.99% yearly.
The Revenue has grown by 15.96% in the past year. This is quite good.
Measured over the past years, IBAB shows a quite strong growth in Revenue. The Revenue has been growing by 12.01% on average per year.
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
3.2 Future
The Earnings Per Share is expected to grow by 58.72% on average over the next years. This is a very strong growth
IBAB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.63% yearly.
EPS Next Y180.98%
EPS Next 2Y112.13%
EPS Next 3Y69.87%
EPS Next 5Y58.72%
Revenue Next Year21.21%
Revenue Next 2Y12.69%
Revenue Next 3Y9.84%
Revenue Next 5Y2.63%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 19.51 indicates a rather expensive valuation of IBAB.
Based on the Price/Earnings ratio, IBAB is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.37, IBAB is valued a bit cheaper.
IBAB is valuated reasonably with a Price/Forward Earnings ratio of 10.24.
87.69% of the companies in the same industry are more expensive than IBAB, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 36.20. IBAB is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.51 | ||
| Fwd PE | 10.24 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IBAB is valued cheaper than 89.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.67 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IBAB's earnings are expected to grow with 69.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.11
PEG (5Y)4.89
EPS Next 2Y112.13%
EPS Next 3Y69.87%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.49%, IBAB has a reasonable but not impressive dividend return.
IBAB's Dividend Yield is a higher than the industry average which is at 2.15.
Compared to the average S&P500 Dividend Yield of 2.32, IBAB is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.49% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
8.05% of the earnings are spent on dividend by IBAB. This is a low number and sustainable payout ratio.
DP8.05%
EPS Next 2Y112.13%
EPS Next 3Y69.87%
EBR:IBAB (12/4/2025, 9:41:59 AM)
11.12
+0.08 (+0.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners26.17%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap336.71M
Revenue(TTM)596.63M
Net Income(TTM)17.00M
Analysts80
Price Target14.96 (34.53%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.49% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP8.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.95%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)3.5%
EPS NY rev (3m)-8.9%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.51 | ||
| Fwd PE | 10.24 | ||
| P/S | 0.56 | ||
| P/FCF | N/A | ||
| P/OCF | 120.95 | ||
| P/B | 2.83 | ||
| P/tB | 3.57 | ||
| EV/EBITDA | 7.67 |
EPS(TTM)0.57
EY5.13%
EPS(NY)1.09
Fwd EY9.77%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.09
OCFY0.83%
SpS19.7
BVpS3.93
TBVpS3.12
PEG (NY)0.11
PEG (5Y)4.89
Graham Number7.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROCE | 25.19% | ||
| ROIC | 15.54% | ||
| ROICexc | 16.45% | ||
| ROICexgc | 19.79% | ||
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% | ||
| FCFM | N/A |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.19%
ROCE(5y)10.93%
ROICexgc growth 3YN/A
ROICexgc growth 5Y52.5%
ROICexc growth 3Y-88.2%
ROICexc growth 5Y50.32%
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
F-Score7
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.54 | ||
| Cap/Depr | 65.94% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 5.44% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 1.61 |
F-Score7
WACC7.17%
ROIC/WACC2.17
Cap/Depr(3y)79.57%
Cap/Depr(5y)64.6%
Cap/Sales(3y)2.05%
Cap/Sales(5y)1.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
EPS Next Y180.98%
EPS Next 2Y112.13%
EPS Next 3Y69.87%
EPS Next 5Y58.72%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
Revenue Next Year21.21%
Revenue Next 2Y12.69%
Revenue Next 3Y9.84%
Revenue Next 5Y2.63%
EBIT growth 1Y38.72%
EBIT growth 3Y27.16%
EBIT growth 5Y65.71%
EBIT Next Year213.8%
EBIT Next 3Y66.86%
EBIT Next 5Y52.9%
FCF growth 1Y90.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y105.87%
OCF growth 3YN/A
OCF growth 5YN/A
ION BEAM APPLICATIONS / IBAB.BR FAQ
Can you provide the ChartMill fundamental rating for ION BEAM APPLICATIONS?
ChartMill assigns a fundamental rating of 4 / 10 to IBAB.BR.
What is the valuation status for IBAB stock?
ChartMill assigns a valuation rating of 6 / 10 to ION BEAM APPLICATIONS (IBAB.BR). This can be considered as Fairly Valued.
How profitable is ION BEAM APPLICATIONS (IBAB.BR) stock?
ION BEAM APPLICATIONS (IBAB.BR) has a profitability rating of 4 / 10.
What is the valuation of ION BEAM APPLICATIONS based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ION BEAM APPLICATIONS (IBAB.BR) is 19.51 and the Price/Book (PB) ratio is 2.83.
What is the earnings growth outlook for ION BEAM APPLICATIONS?
The Earnings per Share (EPS) of ION BEAM APPLICATIONS (IBAB.BR) is expected to grow by 180.98% in the next year.